Yu‐Wei Chang
-
- Epigenetics and DNA Methylation 6
- Ubiquitin and proteasome pathways 5
- Renal and related cancers 3
-
- Pelvic and Acetabular Injuries 4
- Hernia repair and management 4
- Bladder and Urothelial Cancer Treatments 3
-
- Pelvic floor disorders treatments 3
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Kamaleshwar P. SinghKuo‐How HuangWei‐Chou LinKuan-Lin KuoShing‐Hwa LiuYi‐Chen ChenPo‐Ming ChowPrathap Kumar S. Mahalingaiah
- Partner nations
- TaiwanUnited StatesCzechia
In The Last Decade
Yu‐Wei Chang
30 papers receiving 469 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 84
- Molecular Biology 271
- Oncology 105
- Immunology 71
- Biotechnology 25
Countries citing papers authored by Yu‐Wei Chang
This map shows the geographic impact of Yu‐Wei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Wei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Wei Chang more than expected).
Fields of papers citing papers by Yu‐Wei Chang
This network shows the impact of papers produced by Yu‐Wei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Wei Chang. The network helps show where Yu‐Wei Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu‐Wei Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 15 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 20 | |
| 7 | 2019 | 8 | |
| 8 | 2019 | 24 | |
| 9 | 2018 | 35 | |
| 10 | 2018 | 29 | |
| 11 | 2018 | 9 | |
| 12 | 2018 | 19 | |
| 13 | 2017 | 7 | |
| 14 | 2017 | 4 | |
| 15 | 2016 | 15 | |
| 16 | 2016 | 10 | |
| 17 | 2015 | 50 | |
| 18 | 2014 | 20 | |
| 19 | 2013 | 23 | |
| 20 | 2013 | 16 |
About Yu‐Wei Chang
Yu‐Wei Chang is a scholar working on Environmental Chemistry, Oncology and Cell Biology, having authored 31 papers that have together received 472 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Ubiquitin and proteasome pathways (5 papers), Pelvic and Acetabular Injuries (4 papers), Hernia repair and management (4 papers), Pelvic floor disorders treatments (3 papers), Advanced Breast Cancer Therapies (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Cancer Research (84 citations), Molecular Biology (271 citations) and Oncology (105 citations). Yu‐Wei Chang has collaborated with scholars based in Taiwan, United States and Czechia. Frequent co-authors include Kamaleshwar P. Singh, Kuo‐How Huang, Wei‐Chou Lin, Kuan-Lin Kuo, Shing‐Hwa Liu, Yi‐Chen Chen, Po‐Ming Chow, Prathap Kumar S. Mahalingaiah, Cheng‐Wen Wu and Fu‐Tong Liu. Their work appears in journals such as PLoS ONE, Development and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.